Research programme: human papillomavirus therapeutics - LSBC/University of Louisville
Latest Information Update: 26 Apr 2007
Price :
$50 *
At a glance
- Originator Large Scale Biology Corporation (CEASED); University of Louisville
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Human papillomavirus infections; Warts
Most Recent Events
- 23 Dec 2005 Large Scale Biology Corporation ceased operations
- 02 Aug 2004 Preclinical trials in Cancer in USA (Injection)
- 02 Aug 2004 Preclinical trials in Human papillomavirus infections in USA (Injection)